Literature DB >> 6616625

Enhancement of erythrophagocytosis by cyclophosphamide.

M Giordano, M A Isturiz.   

Abstract

The effect of cyclophosphamide (Cy) on erythrophagocytosis carried out by peritoneal exudate cells (PEC) was evaluated. The results indicate that the treatment of BALB/c mice with a single high dose of Cy (200 mg/kg) increases the capability of PEC to ingest sensitized sheep red blood cells. Cy not only increases the percentage of PEC with engulfed erythrocytes, but also augments the activity of individual phagocytes. This effect is exerted upon both mononuclear and polymorphonuclear cells and is probably due to the activation of receptors for the Fc fragment of IgG on PEC membranes, as unsensitized sheep erythrocytes are not phagocytized. Considering that Cy is one of the most used alkylating agents in treatment of immunological disorders and cancer chemotherapy, this enhancing effect on phagocytosis may be important in the regulation of host defense mechanisms.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6616625     DOI: 10.1016/0008-8749(83)90225-3

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

1.  Effect of cyclophosphamide on the candidacidal activity of rabbit peritoneal macrophages.

Authors:  D Kotulová; M Zalkovicová; J Stefanovic
Journal:  Folia Microbiol (Praha)       Date:  1988       Impact factor: 2.099

2.  Host defence mechanisms, antibiotics and immunosuppressive agents--a complex relationship.

Authors:  T E Miller
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

3.  Mifepristone (RU486) restores humoral and T cell-mediated immune response in endotoxin immunosuppressed mice.

Authors:  B Rearte; A Maglioco; L Balboa; J Bruzzo; V I Landoni; E A Laborde; P Chiarella; R A Ruggiero; G C Fernández; M A Isturiz
Journal:  Clin Exp Immunol       Date:  2010-10-21       Impact factor: 4.330

4.  Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice.

Authors:  H Shindo; T Ogura; T Masuno; S Hayashi; S Kishimoto
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.